Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2)

Clinical Endocrinology

Volumn 68, Issue 1, 2008, Pages 102-107

  Morcillo, Sonsoles ^a   Cardona, Fernando ^b   Rojo Martínez, Gemma ^a   Almaraz, M Cruz ^a   Esteva, Isabel ^a   Ruiz De Adana, María Soledad ^a   Olveira, Gabriel ^a   García Fuentes, Eduardo ^a   Gómez Zumaquero, Juan Miguel ^a   Soriguer, Federico ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; BETA 3 ADRENERGIC RECEPTOR;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRY; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POPULATION GENETICS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SEX DIFFERENCE; SPAIN;

ADULT; APOLIPOPROTEIN A-I; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ADRENERGIC, BETA-3; SPAIN; YOUNG ADULT;

EID: 36949033371     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03006.x     Document Type: Article

References (27)

1. Soriguer-Escofet, F., Esteva, I., Rojo-Martinez, G., Ruiz de Adana, S., Catalá, M., Merelo, M., Aguilar, M., Tinahones, F., García- Almeida, J., Gómez-Zumaquero, J., Cuesta-Muñoz, A., Ortego, J. Freire, J. (2002) Prevalence of latent autoimmune diabetes of adults (LADA) in southern Spain. Diabetes Research and Clinical Practice, 56, 213 220.
2. Bastian, W. (2002) Genes with linkage or association with type 2 diabetes mellitus. Journal of Pediatric Endocrinology and Metabolism, 15 (Suppl. 1 471 484.
3. Ochoa, M., Marti, A., Azcona, C., Chueca, M., Oyarzábal, M., Pelach, R., Patiño, A., Moreno-Aliaga, M., Martínez- González, M. Martínez, J. (2004) Gene-gene interaction between PPAR gamma 2 and ADR beta 3 increases obesity risk in children and adolescents. International Journal of Obesity and Related Metabolic Disorders, 28 (Suppl. 3 S37 S41.
4. Hsueh, W., Cole, S., Shuldiner, A., Beamer, B., Blangero, J., Hixson, J., MacCluer, J. Mitchell, B. (2001) Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferator-activated receptor-gamma2 genes and obesity. Diabetes Care, 24, 672 677.
5. Walston, J., Silver, K., Bogardus, C., Knowler, W., Celi, F., Austin, S., Manning, B., Strosberg, A., Stern, M. Raben, N. (1995) Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. New England Journal of Medicine, 333, 343 347.
6. Morcillo, S., Cardona, F., Rojo-Martínez, G., Esteva, I., Ruíz-de-Adana, M., Tinahones, F., Gómez-Zumaquero, J. Soriguer, F. (2005) Association between MspI polymorphism of the APO AI gene and type 2 diabetes mellitus. Diabetic Medicine, 22, 782 788.
7. Strosberg, A. (1997) Association of beta 3-adrenoceptor polymorphism with obesity and diabetes: current status. Trends in Pharmacological Sciences, 18, 449 454.
8. Groenendijk, M., Cantor, R., de Bruin, T. Dallinga-Thie, G. (2001) The apoAI-CIII-AIV gene cluster. Atherosclerosis, 157, 1 11.
9. Ma, Y., Thomas, G., Ng, M., Critchley, J., Cockram, C., Chan, J. Tomlinson, B. (2003) Association of two apolipoprotein A-I gene MspI polymorphisms with high density lipoprotein (HDL)-cholesterol levels and indices of obesity in selected healthy Chinese subjects and in patients with early-onset type 2 diabetes. Clinical Endocrinology, 59, 442 449.
10. Buraczynska, M., Hanzlik, J. Grzywa, M. (1985) Apolipoprotein A-I gene polymorphism and susceptibility of non-insulin-dependent diabetes mellitus. American Journal of Human Genetics, 37, 1129 1137.
11. Xiang, K., Cox, N., Sanz, N., Huang, P., Karam, J. Bell, G. (1989) Insulin-receptor and apolipoprotein genes contribute to development of NIDDM in Chinese Americans. Diabetes, 38, 17 23.
12. Mooradian, A., Haas, M. Wong, N. (2004) Transcriptional control of apolipoprotein A-I gene expression in diabetes. Diabetes, 53, 513 520.
13. Large, V. Arner, P. (1998) Regulation of lipolysis in humans: pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes & Metabolism, 24, 409 418.
14. Soriguer, F., Rojo-Martínez, G., Dobarganes, M., García Almeida, J., Esteva, I., Beltrán, M., Ruiz De Adana, M., Tinahones, F., Gómez-Zumaquero, J., García-Fuentes, E. González-Romero, S. (2003) Hypertension is related to the degradation of dietary frying oils. American Journal of Clinical Nutrition, 78, 1092 1097.
15. Institute of Statistics of Andalusia (1996) Municipal information system of Andalucia. Council of Andalusia, Seville, Spain.
16. Alberti, K. Zimmet, P. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15, 539 553.
17. Matthews, D., Hosker, J., Rudenski, A., Naylor, B., Treacher, D. Turner, R. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412 419.
18. Queipo-Ortuño, M., Garcia-Ordoñez, M., Colmenero, J. Morata, P. (1999) Hydrogen peroxide improves the efficiency of a peripheral blood PCR assay for diagnosis of human brucellosis. Biotechniques, 27, 252.
19. Jeenah, M., Kessling, A., Miller, N. Humphries, S. (1990) G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Molecular and Biological Medicine, 7, 233 241.
20. Gauderman, W.J. (2002) Sample size requirements for association studies of gene-gene interaction. American Journal of Epidemiology, 155, 478 484.
21. Zhan, S. Ho, S. (2005) Meta-analysis of the association of the Trp64Arg polymorphism in the beta3 adrenergic receptor with insulin resistance. Obesity Research, 13, 1709 1719.
22. Büettner, R., Schäffler, A., Arndt, H., Rogler, G., Nusser, J., Zietz, B., Enger, I., Hügl, S., Cuk, A., Schölmerich, J. Palitzsch, K. (1998) The Trp64Arg polymorphism of the beta 3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort. Journal of Clinical Endocrinology and Metabolism, 83, 2892 2897.
23. Fujisawa, T., Ikegami, H., Yamato, E., Takekawa, K., Nakagawa, Y., Hamada, Y., Oga, T., Ueda, H., Shintani, M., Fukuda, M. Ogihara, T. (1996) Association of Trp64Arg mutation of the beta3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia, 39, 349 352.
24. Park, H., Kim, Y. Lee, C. (2005) Single nucleotide variants in the beta2-adrenergic and beta3-adrenergic receptor genes explained 18.3% of adolescent obesity variation. Journal of Human Genetics, 50, 365 369.
25. Valve, R., Heikkinen, S., Rissanen, A., Laakso, M. Uusitupa, M. (1998) Synergistic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on basal metabolic rate in obese Finns. Diabetologia, 41, 357 361.
26. Kawashiri, M., Maugeais, C. Rader, D. (2000) High-density lipoprotein metabolism: molecular targets for new therapies for atherosclerosis. Current Atherosclerosis Reports, 2, 363 372.
27. Garg, A. Grundy, S. (1990) Management of dyslipidemia in NIDDM. Diabetes Care, 13, 153 169.